Sentences with phrase «among lung cancer patients»

Though it was already approved for melanoma, FDA regulators requested more detailed data from its latest trial to make certain that it will eventually improve survival rates among lung cancer patients.

Suicide risk is highest among lung cancer patients, particularly older patients, widowed, males, and patients with unfavorable tumor characteristics.

Among lung cancer patients; suicide SMR was higher in males (SMR = 8.8), Asians (SMR = 13.7), widowed patients (SMR = 11.6), older patients (70 - 75 years; SMR = 12), patients with undifferentiated tumors (SMR 8.6) or small cell lung carcinoma (SCLC) histology (SMR = 11.2), patients presenting with metastatic disease (SMR = 13.9) and in patients who refused to receive surgical treatment (SMR = 13).

Among lung cancer patients, Asians have a more than 13-fold and men a nearly 9-fold increase in suicides.

Not exact matches

Among patients who have this type of lung cancer, nearly one in three will carry a particular genetic mutation on their cancer cells.

Among patients with non-small cell lung cancer (NSCLC) fueled by ALK gene alterations who were being treated with crizotinib (Xalkori), a decrease in the number of circulating tumor cells (CTCs) harboring increased copies of the ALK gene over the first two months of treatment was associated with increased progression - free survival.

Among patients with advanced non-small cell lung cancer without a mutation of a certain gene (EGFR), conventional chemotherapy, compared with treatment using epidermal growth factor receptor tyrosine kinase inhibitors, was associated with improvement in survival without progression of the cancer, but not with overall survival, according to a study in the April 9 issue of JAMA.

Among patients with metastatic lung cancer, comorbidity had less impact on survival.

Islam and colleagues found that among patients with localized lung cancer, those with one comorbidity had a 30 percent higher risk of mortality compared with those who had no comorbidity.

An anti-PD-1 antibody developed by Bristol - Myers Squibb generates excitement with results from a phase I trial showing that, among 236 patients with various types of cancer, the treatment shrank tumors in 28 percent of melanoma patients, 30 percent of patients with kidney cancer, and 18 percent of patients with advanced non-small cell lung cancer.

$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung Cancer Ribbon?

Now, on Nov. 5, a news story likened those findings to the results of a large trial by the National Cancer Institute, which showed that CT scans reduced mortality rates among the highest - risk lung cancer patients by 20 peCancer Institute, which showed that CT scans reduced mortality rates among the highest - risk lung cancer patients by 20 pecancer patients by 20 percent.

Among the most exciting findings of these studies is that a significant proportion of patients with non-small cell lung cancer (NSCLC) respond dramatically to anti-PD-1 treatment.

The work that garnered the honor, «An analysis of the risk and benefit of neoadjuvant chemotherapy among patients undergoing surgery for non-small cell lung cancer,» examined data from more than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term surcancer,» examined data from more than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term surCancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term survival.

Pharmaceutical giant Merck's flagship immunotherapy drug that was just approved by the United States Food and Drug Administration (FDA) shows promise in the overall survival rate among patients suffering from one of the deadliest type of cancer that affects the lungs.

«Controversy unfortunately still exists among providers of the cost benefit of screening,» he explained, «while patients at risk of lung cancer also lack adequate awareness of the benefits of screening.»

I have seen many more cases of lung cancer among nonsmokers than smokers in the thousands of patients I have cared for over the past thirty years, but that doesn't negate the studies done on the subject that show only about 15 % of lung cancer cases occur in nonsmokers.

These findings are consistent with previous research, in which caregiving burden among spouses of patients with lung cancer was related to 3 - and 6 - month follow - up distress in spouses.